AN2 Therapeutics Ownership | Who Owns AN2 Therapeutics?
AN2 Therapeutics Ownership Summary
AN2 Therapeutics is owned by 47.72% institutional investors, 22.84% insiders, and 29.45% retail investors. Bml capital management is the largest institutional shareholder, holding 19.27% of ANTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.49% of its assets in AN2 Therapeutics shares.
ANTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | AN2 Therapeutics | 47.72% | 22.84% | 29.45% |
| Sector | Healthcare Stocks | 279.17% | 10.51% | -189.68% |
| Industry | Biotech Stocks | 63.95% | 10.67% | 25.38% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bml capital management | 5.75M | 19.27% | $7.93M |
| Citadel advisors | 1.55M | 5.22% | $3.34M |
| Almitas capital | 1.31M | 4.40% | $1.81M |
| Vanguard group | 1.04M | 3.47% | $1.43M |
| Pfizer | 715.29K | 2.40% | $987.11K |
| Renaissance | 579.77K | 1.94% | $800.09K |
| Two sigma advisers, lp | 528.30K | 1.77% | $729.05K |
| Bank of montreal /can/ | 422.08K | 1.41% | $582.47K |
| Two sigma investments, lp | 400.33K | 1.34% | $552.46K |
| Bank of nova scotia | 394.87K | 1.32% | $544.92K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bml capital management | 5.75M | 4.93% | $7.93M |
| Aldebaran capital | 343.68K | 0.45% | $474.28K |
| Almitas capital | 1.31M | 0.40% | $1.81M |
| Pfizer | 715.29K | 0.04% | $987.11K |
| Bridgeway capital management | 162.20K | 0.01% | $223.84K |
| Two sigma advisers, lp | 528.30K | 0.00% | $729.05K |
| Renaissance | 579.77K | 0.00% | $800.09K |
| Two sigma investments, lp | 400.33K | 0.00% | $552.46K |
| Bank of nova scotia | 394.87K | 0.00% | $544.92K |
| Adage capital partners gp | 312.62K | 0.00% | $431.41K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Almitas capital | 1.31M | 0.40% | 1.31M |
| Pfizer | 715.29K | 0.04% | 715.29K |
| Bank of montreal /can/ | 422.08K | 0.00% | 422.08K |
| Two sigma advisers, lp | 528.30K | 0.00% | 407.40K |
| Bank of nova scotia | 394.87K | 0.00% | 394.87K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Octagon capital advisors lp | - | - | -3.22M |
| Frazier life sciences management | - | - | -2.09M |
| Ra capital management | - | - | -2.00M |
| Tcg crossover management | - | - | -1.56M |
| Bvf inc/il | - | - | -1.24M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Almitas capital | 1.31M | 0.40% | 1.31M | $1.81M |
| Pfizer | 715.29K | 0.04% | 715.29K | $987.11K |
| Bank of montreal /can/ | 422.08K | 0.00% | 422.08K | $582.47K |
| Bank of nova scotia | 394.87K | 0.00% | 394.87K | $544.92K |
| Royal bank of canada | 2.81K | - | 2.81K | $6.00K |
Sold Out
| Holder | Change |
|---|---|
| Wells fargo & company/mn | -128.00 |
| Fmr | -300.00 |
| California state teachers retirement system | -9.25K |
| Clear street markets | -10.00K |
| Atom investors lp | -11.90K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 37 | - | 14,340,830 | -1.29% | 47 | 2.01% | 13 | -45.83% | 11 | 57.14% |
| Dec 31, 2024 | 37 | 19.35% | 14,528,930 | 7.52% | 48 | 2.37% | 24 | 50.00% | 7 | - |
| Sep 30, 2024 | 31 | -31.11% | 13,513,224 | -30.40% | 45 | 1.06% | 16 | -20.00% | 7 | -46.15% |
| Jun 30, 2024 | 45 | -16.67% | 19,415,909 | 3.64% | 65 | 1.04% | 20 | -35.48% | 13 | -18.75% |
| Mar 31, 2024 | 54 | 5.88% | 18,733,564 | -8.13% | 79 | 1.26% | 31 | -3.13% | 16 | 60.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 749.42K | 2.49% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 261.93K | 0.87% | - |
| Fidelity Extended Market Index | 120.64K | 0.40% | 5.59K |
| Bridgeway Ultra-Small Company Market | 59.00K | 0.20% | -102.30K |
| Fidelity Total Market Index | 48.90K | 0.16% | 17.73K |
| BlackRock Extended Equity Market K | 33.77K | 0.11% | -14.00 |
| Bridgeway Ultra-Small Company | 33.20K | 0.11% | 33.20K |
| Extended Equity Market Fund K | 33.42K | 0.11% | 102.00 |
| iShares Micro-Cap ETF | 31.78K | 0.11% | - |
| Fidelity Series Total Market Index | 28.46K | 0.09% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 02, 2025 | Easom Eric | Chief Executive Officer | Buy | $10.66K |
| May 28, 2025 | Leonard Braden Michael | - | Sell | $2.32M |
| May 28, 2025 | Leonard Braden Michael | - | Sell | $116.00K |
| May 30, 2025 | Leonard Braden Michael | - | Sell | $429.25K |
| May 30, 2025 | Leonard Braden Michael | - | Sell | $7.23K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 2 | 4 |
| 2025 Q1 | - | 4 |
| 2024 Q4 | 18 | - |
| 2024 Q3 | 1 | 2 |
| 2024 Q2 | - | - |
ANTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools